Opportunity Information: Apply for RFA DK 26 001
The NIDDK Centers for Diabetes Translation Research (CDTR) funding opportunity (RFA-DK-26-001) is a National Institutes of Health (NIH) P30 center grant designed to strengthen and speed up diabetes translation research, specifically across the T2 to T4 spectrum. In practical terms, it focuses on moving evidence from clinical discovery and early testing into real-world clinical practice, health systems, and community settings, and then studying how best to disseminate and implement proven interventions at scale. The overarching goal is to maximize the population-level impact of diabetes research by building a coordinated center that provides shared infrastructure, specialized expertise, and practical support services to investigators working on translation, dissemination, and implementation questions.
A central expectation of this program is that funded centers will operate through a set of shared cores that make research more efficient and more collaborative. Rather than supporting isolated projects, the CDTR model emphasizes cost-effective shared resources that increase productivity, create synergy among investigators, and generate new translational research ideas. These cores can include services such as methodology and study design support for pragmatic and implementation trials, community-engaged research capabilities, measurement and evaluation support, data and informatics resources, training and education offerings, and other specialized tools that help investigators move diabetes interventions into routine care and community practice.
Health equity and reduction of diabetes-related disparities are strongly emphasized. Applications are encouraged to incorporate novel methods and research approaches that directly address inequities in diabetes prevention, treatment, and outcomes across populations and settings. The announcement also allows for innovative cores that focus on other person-centered, community, or population health priorities, as long as applicants clearly justify how the resulting findings or strategies could be adapted to meaningfully inform disparity-reduction efforts. In other words, even if a core is not solely devoted to disparities, it should still have a plausible pathway to advancing equity-focused translation.
The NOFO also signals that a strong scientific base and partnership network are expected. Successful CDTR applications should reflect an ecosystem that includes academic investigators and diverse collaborators such as healthcare systems, community organizations, public health departments, and human services organizations. This collaborative structure is intended to ensure that interventions and implementation strategies are grounded in real-world needs and can be tested, refined, and scaled in the settings where people actually receive care and support.
In terms of administrative details, this is a discretionary grant mechanism with a funding activity category in health (and related food and nutrition areas) under CFDA 93.847. Clinical trials are listed as optional, which generally means the center may support trial-related translational and implementation work when appropriate, but a clinical trial is not required for every component. The original application closing date is June 10, 2025, and the opportunity was created on December 9, 2024. The provided listing does not specify an award ceiling or the anticipated number of awards in the excerpted fields.
Eligibility is broad and includes many types of domestic entities: state, county, and local governments; special districts; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (including those other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The NOFO explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, it clearly excludes foreign participation in key ways: non-U.S. (foreign) organizations are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
Overall, the opportunity is aimed at building robust, collaborative, equity-centered translation research centers that can help close the gap between what is known to work in diabetes care and what is consistently delivered in clinics, health systems, and communities, with shared cores and partnerships designed to make that translation faster, more rigorous, and more impactful at the population level.Apply for RFA DK 26 001
- The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
- This funding opportunity was created on 2024-12-09.
- Applicants must submit their applications by 2025-06-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): NIDDK Centers for Diabetes Translation Research (CDTR) - RFA-DK-26-001
1. What is the CDTR funding opportunity (RFA-DK-26-001)?
The NIDDK Centers for Diabetes Translation Research (CDTR) opportunity (RFA-DK-26-001) is a National Institutes of Health (NIH) P30 center grant. It is designed to strengthen and speed up diabetes translation research by building coordinated centers that provide shared infrastructure, specialized expertise, and practical support services for investigators.
2. What is the main purpose of a CDTR center?
The purpose is to maximize the population-level impact of diabetes research by closing the gap between what is known to work and what is routinely delivered in clinical practice, health systems, and community settings. CDTR centers are intended to make translational research more efficient, collaborative, and scalable through shared cores and partnerships.
3. What stages of translation does the CDTR program focus on?
The program focuses specifically on the T2 to T4 spectrum. In practical terms, it emphasizes moving evidence from clinical discovery and early testing into real-world settings (clinics, health systems, and communities) and studying how proven interventions can be disseminated and implemented at scale.
4. Does this opportunity fund individual research projects?
Based on the description provided, the CDTR model emphasizes shared cores and shared resources rather than supporting isolated projects. The intent is to increase productivity and synergy among investigators by offering cost-effective infrastructure and services that many investigators can use.
5. What are “cores” in the CDTR model?
Cores are shared center components that provide common services, tools, and expertise to help investigators conduct translational, dissemination, and implementation research more effectively. They are a central expectation of how CDTR centers will operate.
6. What kinds of services can CDTR cores provide?
Examples mentioned include: methodology and study design support for pragmatic and implementation trials, community-engaged research capabilities, measurement and evaluation support, data and informatics resources, training and education offerings, and other specialized tools that help move diabetes interventions into routine care and community practice.
7. Are applicants allowed to propose innovative or non-traditional cores?
Yes. The opportunity allows for innovative cores, including those focused on person-centered, community, or population health priorities, as long as the applicant clearly justifies how the work could be adapted to meaningfully inform efforts to reduce diabetes-related disparities.
8. How important is health equity in this funding opportunity?
Health equity and reduction of diabetes-related disparities are strongly emphasized. Applications are encouraged to use novel methods and research approaches that directly address inequities in diabetes prevention, treatment, and outcomes across populations and settings.
9. If a core is not solely focused on disparities, can it still fit the program?
Yes. Even if a core is not exclusively devoted to disparities, the program expects a plausible pathway showing how the resulting findings or strategies could be adapted to advance equity-focused translation and disparity-reduction efforts.
10. What types of partnerships are expected for a competitive CDTR application?
The program signals that a strong scientific base and partnership network are expected. Successful applications should reflect an ecosystem that includes academic investigators and diverse collaborators such as healthcare systems, community organizations, public health departments, and human services organizations.
11. Why does the NOFO emphasize partnerships with real-world organizations?
The collaborative structure is intended to ensure that interventions and implementation strategies are grounded in real-world needs and can be tested, refined, and scaled in the settings where people actually receive care and support.
12. What grant mechanism is used for this opportunity?
This is an NIH P30 center grant mechanism, described as a discretionary grant mechanism in the provided information.
13. What is the funding activity category and CFDA number listed?
The funding activity category is listed as health (and related food and nutrition areas), under CFDA 93.847.
14. Are clinical trials required under this opportunity?
Clinical trials are listed as optional. This generally indicates the center may support trial-related translational and implementation work when appropriate, but a clinical trial is not required for every component.
15. When is the application closing date?
The original application closing date is June 10, 2025.
16. When was this opportunity created?
The opportunity was created on December 9, 2024.
17. Is the award ceiling provided in the listing excerpt?
No. The provided listing does not specify an award ceiling in the excerpted fields.
18. Is the anticipated number of awards provided in the listing excerpt?
No. The provided listing does not specify the anticipated number of awards in the excerpted fields.
19. Who is eligible to apply?
Eligibility is broad and includes many types of domestic entities, including: state, county, and local governments; special districts; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses.
20. Are specific institution types explicitly highlighted as eligible?
Yes. The NOFO explicitly highlights additional eligible applicant categories such as HBCUs, Hispanic-serving Institutions, TCCUs, Alaska Native and Native Hawaiian Serving Institutions, and AANAPISISs. It also mentions faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
21. Are foreign organizations eligible to apply?
No. Non-U.S. (foreign) organizations are not eligible to apply.
22. Can a U.S. organization include a non-domestic component?
No. Non-domestic components of U.S. organizations are not eligible.
23. Are foreign components allowed under NIH policy for this opportunity?
No. Foreign components (as defined by NIH policy) are not allowed.
24. What makes the CDTR approach different from a traditional research program?
Based on the description provided, the CDTR approach is center-based and infrastructure-driven. Rather than funding isolated efforts, it aims to create coordinated, shared resources (cores) that improve efficiency, increase collaboration, generate new translational ideas, and support dissemination and implementation at scale in real-world settings.
25. What is the overall goal of the CDTR program?
The overall goal is to build robust, collaborative, equity-centered translation research centers that speed up and strengthen diabetes translation research, helping proven interventions move into consistent real-world delivery and improving population-level outcomes.
Browse more opportunities from the same category: Food and Nutrition, Health
Next opportunity: Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Previous opportunity: 2025 Alumni Engagement Innovation Fund (AEIF 2025)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 26 001
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 26 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) Apply for PAR 25 277 Funding Number: PAR 25 277 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Continuation of the NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA DK 25 023 Funding Number: RFA DK 25 023 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) Apply for RFA DK 26 006 Funding Number: RFA DK 26 006 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $500,000 |
| NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required) Apply for PA 25 147 Funding Number: PA 25 147 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed) Apply for PAR 25 089 Funding Number: PAR 25 089 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) Apply for PAS 25 073 Funding Number: PAS 25 073 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional) Apply for PAR 25 097 Funding Number: PAR 25 097 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $125,000 |
| Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed) Apply for PAR 25 068 Funding Number: PAR 25 068 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required) Apply for PAS 25 102 Funding Number: PAS 25 102 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $200,000 |
| Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) Apply for PAR 25 091 Funding Number: PAR 25 091 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $75,000 |
| NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) Apply for PAR 25 090 Funding Number: PAR 25 090 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $225,000 |
| Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed) Apply for RFA DK 26 007 Funding Number: RFA DK 26 007 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed) Apply for RFA DK 26 009 Funding Number: RFA DK 26 009 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $100,000 |
| Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required) Apply for RFA DK 26 315 Funding Number: RFA DK 26 315 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 26 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.